open access
False-positive radioiodine whole-body scan due to a renal cyst
- Department of Endocrinology, Metabolism, and Internal Medicine, Poznan University of Medical Sciences, Poznan, Poland
open access
Abstract
Patients affected by differentiated thyroid cancer are treated surgically and by ablative radioiodine therapy. A post-therapy whole-body scan allows detection of thyroid remnants or local and distant metastases, although false-positive findings may be observed. We report a case of a 75-year-old woman with follicular thyroid cancer, who underwent ablative radioiodine treatment. On post-therapy wholebody scan, abnormal uptake in the left upper abdomen was found, although stimulated thyroglobulin level was not suggestive for distant metastases of differentiated thyroid carcinoma. Additional SPECT/CT acquisition revealed focal 131I uptake located at the posterolateral wall of the left kidney corresponding to a round lesion 47 mm in maximal diameter. In order to verify this finding abdominal ultrasound and abdominal contrast-enhanced CT were performed, confirming multiple renal cysts in the left kidney; the largest one was the site of abnormal radioiodine accumulation. Despite the high incidence of renal cysts, especially in the elderly, radioiodine uptake in renal cysts
is extremely rare. Different hypotheses on the mechanism of radioiodine uptake in the cyst were proposed, among them active secretion by sodium-iodide symporter or other transporting proteins. We conclude that abnormal radioiodine uptake in renal cysts can be an exceptional finding mimicking a metastasis.
Abstract
Patients affected by differentiated thyroid cancer are treated surgically and by ablative radioiodine therapy. A post-therapy whole-body scan allows detection of thyroid remnants or local and distant metastases, although false-positive findings may be observed. We report a case of a 75-year-old woman with follicular thyroid cancer, who underwent ablative radioiodine treatment. On post-therapy wholebody scan, abnormal uptake in the left upper abdomen was found, although stimulated thyroglobulin level was not suggestive for distant metastases of differentiated thyroid carcinoma. Additional SPECT/CT acquisition revealed focal 131I uptake located at the posterolateral wall of the left kidney corresponding to a round lesion 47 mm in maximal diameter. In order to verify this finding abdominal ultrasound and abdominal contrast-enhanced CT were performed, confirming multiple renal cysts in the left kidney; the largest one was the site of abnormal radioiodine accumulation. Despite the high incidence of renal cysts, especially in the elderly, radioiodine uptake in renal cysts
is extremely rare. Different hypotheses on the mechanism of radioiodine uptake in the cyst were proposed, among them active secretion by sodium-iodide symporter or other transporting proteins. We conclude that abnormal radioiodine uptake in renal cysts can be an exceptional finding mimicking a metastasis.
Keywords
follicular thyroid cancer; renal cyst; radioiodine; post-therapy whole-body scan
Title
False-positive radioiodine whole-body scan due to a renal cyst
Journal
Issue
Article type
Case report
Pages
736-739
Published online
2018-10-11
Page views
3545
Article views/downloads
1207
DOI
Pubmed
Bibliographic record
Endokrynol Pol 2018;69(6):736-739.
Keywords
follicular thyroid cancer
renal cyst
radioiodine
post-therapy whole-body scan
Authors
Adam Maciejewski
Rafał Czepczyński
Marek Ruchała
- Jarząb B, Dedecjus M, Słowińska-Klencka D, et al. Guidelines of Polish National Societies Diagnostics and Treatment of Thyroid Carcinoma. 2018 Update. Endokrynol Pol. 2018; 69(1): 34–74.
- Simms RJ, Ong ACM. How simple are 'simple renal cysts'? Nephrol Dial Transplant. 2014; 29(Suppl 4): iv106–iv112.
- Chang CC, Kuo JY, Chan WL, et al. Prevalence and clinical characteristics of simple renal cyst. J Chin Med Assoc. 2007; 70(11): 486–491.
- Campennì A, Ruggeri RM, Giovinazzo S, et al. Radioiodine uptake in a renal cyst mimicking a metastasis in a patient affected by differentiated thyroid cancer: case report and review of the literature. Ann Nucl Med. 2014; 28(5): 472–476.
- Mi YX, Sui X, Huang JM, et al. Incidentally polycystic kidney disease identified by SPECT/CT with post-therapy radioiodine scintigraphy in a patient with differentiated thyroid carcinoma: A case report. Medicine (Baltimore). 2017; 96(43): e8348.
- Grantham JJ. 1992 Homer Smith Award. Fluid secretion, cellular proliferation, and the pathogenesis of renal epithelial cysts. J Am Soc Nephrol. 1993; 3(12): 1841–1857.
- Wapnir IL, van de Rijn M, Nowels K, et al. Immunohistochemical profile of the sodium/iodide symporter in thyroid, breast, and other carcinomas using high density tissue microarrays and conventional sections. J Clin Endocrinol Metab. 2003; 88(4): 1880–1888.
- Spitzweg C, Dutton CM, Castro MR, et al. Expression of the sodium iodide symporter in human kidney. Kidney Int. 2001; 59(3): 1013–1023.
- Ravera S, Reyna-Neyra A, Ferrandino G, et al. The Sodium/Iodide Symporter (NIS): Molecular Physiology and Preclinical and Clinical Applications. Annu Rev Physiol. 2017; 79: 261–289.
- Pesce L, Bizhanova A, Caraballo JC, et al. TSH regulates pendrin membrane abundance and enhances iodide efflux in thyroid cells. Endocrinology. 2012; 153(1): 512–521.
- Kim YH, Pham TD, Zheng W, et al. Role of pendrin in iodide balance: going with the flow. Am J Physiol Renal Physiol. 2009; 297(4): F1069–F1079.
- Nair LM, Anila KR, Sreekumar A, et al. Renal metastasis from papillary carcinoma thyroid detected by whole body iodine scan: A case report and review of the literature. Indian J Nucl Med. 2016; 31(3): 232–234.
- Smallridge RC, Castro MR, Morris JC, et al. Renal metastases from thyroid papillary carcinoma: study of sodium iodide symporter expression. Thyroid. 2001; 11(8): 795–804.
- Chudgar AV, Shah JC. Pictorial Review of False-Positive Results on Radioiodine Scintigrams of Patients with Differentiated Thyroid Cancer. Radiographics. 2017; 37(1): 298–315.
- Czepczyński R, Wyszomirska A, Gryczyńska M, et al. Cerebellar metastasis of papillary thyroid carcinoma detected with somatostatin receptor scintigraphy. Endokrynol Pol. 2018; 69(1): 24–27.